SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-036239
Filing Date
2021-05-27
Accepted
2021-05-27 16:16:51
Documents
1
Period of Report
2021-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3071
  Complete submission text file 0001209191-21-036239.txt   4487
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 (215) 921-7600
AMICUS THERAPEUTICS, INC. (Issuer) CIK: 0001178879 (see all company filings)

IRS No.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 333 WEST 11TH STREET KANSAS CITY MO 64105
Business Address
Bleil Lynn Dorsey (Reporting) CIK: 0001607309 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33497 | Film No.: 21972904